Pan-cancer prognostic models of clinical outcomes: statistical exercise or clinical tools?
- 2 September 2020
- journal article
- editorial
- Published by Elsevier BV in Annals of Oncology
- Vol. 31 (11), 1427-1429
- https://doi.org/10.1016/j.annonc.2020.08.2233
Abstract
No abstract availableFunding Information
- Medical Research and Materiel Command
This publication has 19 references indexed in Scilit:
- American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicineCA: A Cancer Journal for Clinicians, 2016
- Identification of a multi-cancer gene expression biomarker for cancer clinical outcomes using a network-based algorithmScientific Reports, 2015
- A Genomic Classifier Improves Prediction of Metastatic Disease Within 5 Years After Surgery in Node-negative High-risk Prostate Cancer Patients Managed by Radical Prostatectomy Without Adjuvant TherapyEuropean Urology, 2015
- Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and ElaborationAnnals of Internal Medicine, 2015
- Molecular Analysis for Therapy Choice: NCI MATCHSeminars in Oncology, 2014
- Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate CancerJournal of Clinical Oncology, 2014
- Tumour heterogeneity in the clinicNature, 2013
- Influence of tumour micro-environment heterogeneity on therapeutic responseNature, 2013
- Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401Journal of Clinical Oncology, 2012
- A Preoperative Nomogram for Disease Recurrence Following Radical Prostatectomy for Prostate CancerJNCI Journal of the National Cancer Institute, 1998